Concord Biotech Limited (NSE:CONCORDBIO)

India · Delayed Price · Currency is INR

1,238.50

+72.30 (6.20%)

Jun 3, 2026, 12:41 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Manufacturing and trading in pharmaceutical products	10.55B	12.00B	10.17B	8.53B	7.13B
Manufacturing and trading in pharmaceutical products Growth	-12.10%	18.01%	19.20%	19.67%	15.56%
Total	10.55B	12.00B	10.17B	8.53B	7.13B
Total Growth	-12.10%	18.01%	19.20%	19.67%	15.56%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	6.62B	5.34B	4.32B	3.39B
India Growth	23.89%	23.62%	27.40%	34.25%
America	1.38B	1.08B	1.47B	1.31B
America Growth	27.77%	-26.67%	12.02%	-17.74%
Others	4.00B	3.75B	2.74B	2.42B
Others Growth	6.81%	36.88%	13.00%	18.48%
Total	12.00B	10.17B	8.53B	7.13B
Total Growth	18.01%	19.20%	19.67%	15.56%

Source: S&P Global Market Intelligence.